Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Bartenstein

Showing results (431-440 of 546) with videos related to

Pageof 55
Sort By:
Nuklearmedizin. Nuclear Medicine|February 16, 2019
[Dopamine Transporter SPECT with I-123 labelled FP-CIT (DaTSCANTM)]Klaus Tatsch, Ralph Buchert, Peter Bartenstein, et al.
The American Journal of Psychiatry|October 7, 2004
Correlation between dopamine D(2) receptors in the ventral striatum and central processing of alcohol cues and cravingAndreas Heinz, Thomas Siessmeier, Jana Wrase, et al.
Neuroendocrinology|April 6, 2025
Upregulation of SSTR2 expression and radioligand binding of [18F]SiTATE in neuroendocrine tumour cells with combined inhibition of class I HDACs and LSD1Christoph J Auernhammer, Kathrin Zitzmann, Simon Lindner, et al.
Frontiers in Neurology|July 6, 2018
Clinical Routine FDG-PET Imaging of Suspected Progressive Supranuclear Palsy and Corticobasal Degeneration: A Gatekeeper for Subsequent Tau-PET Imaging?Leonie Beyer, Johanna Meyer-Wilmes, Sonja Schönecker, et al.
Gastroenterology|June 9, 2009
Combined targeted treatment to eliminate tumorigenic cancer stem cells in human pancreatic cancerMaria-Theresa Mueller, Patrick C Hermann, Juliane Witthauer, et al.
Frontiers in Oncology|October 18, 2021
A Multi-Institutional Analysis of Prostate Cancer Patients With or Without 68Ga-PSMA PET/CT Prior to Salvage Radiotherapy of the Prostatic FossaNina-Sophie Schmidt-Hegemann, Constantinos Zamboglou, Reinhard Thamm, et al.
Neuroimage. Clinical|August 10, 2019
Neuronal injury biomarkers for assessment of the individual cognitive reserve in clinically suspected Alzheimer's diseaseLeonie Beyer, Jonas Schnabel, Philipp Kazmierczak, et al.
Frontiers in Aging Neuroscience|February 16, 2017
Increase of TREM2 during Aging of an Alzheimer's Disease Mouse Model Is Paralleled by Microglial Activation and AmyloidosisMatthias Brendel, Gernot Kleinberger, Federico Probst, et al.
Frontiers in Oncology|June 7, 2021
Feasibility of Different Tumor Delineation Approaches for <sup>18</sup>F-PSMA-1007 PET/CT Imaging in Prostate Cancer PatientsLena M Mittlmeier, Matthias Brendel, Leonie Beyer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 14, 2018
Outcome after PSMA PET/CT based salvage radiotherapy in patients with biochemical recurrence after radical prostatectomy: a bi-institutional retrospective analysisNina-Sophie Schmidt-Hegemann, Christian Stief, Tak-Hyun Kim, et al.
Pageof 55

Showing results (431-440 of 546) with videos related to

Sort By:
Pageof 55
Nuklearmedizin. Nuclear Medicine|February 16, 2019
[Dopamine Transporter SPECT with I-123 labelled FP-CIT (DaTSCANTM)]Klaus Tatsch, Ralph Buchert, Peter Bartenstein, et al.
The American Journal of Psychiatry|October 7, 2004
Correlation between dopamine D(2) receptors in the ventral striatum and central processing of alcohol cues and cravingAndreas Heinz, Thomas Siessmeier, Jana Wrase, et al.
Neuroendocrinology|April 6, 2025
Upregulation of SSTR2 expression and radioligand binding of [18F]SiTATE in neuroendocrine tumour cells with combined inhibition of class I HDACs and LSD1Christoph J Auernhammer, Kathrin Zitzmann, Simon Lindner, et al.
Frontiers in Neurology|July 6, 2018
Clinical Routine FDG-PET Imaging of Suspected Progressive Supranuclear Palsy and Corticobasal Degeneration: A Gatekeeper for Subsequent Tau-PET Imaging?Leonie Beyer, Johanna Meyer-Wilmes, Sonja Schönecker, et al.
Gastroenterology|June 9, 2009
Combined targeted treatment to eliminate tumorigenic cancer stem cells in human pancreatic cancerMaria-Theresa Mueller, Patrick C Hermann, Juliane Witthauer, et al.
Frontiers in Oncology|October 18, 2021
A Multi-Institutional Analysis of Prostate Cancer Patients With or Without 68Ga-PSMA PET/CT Prior to Salvage Radiotherapy of the Prostatic FossaNina-Sophie Schmidt-Hegemann, Constantinos Zamboglou, Reinhard Thamm, et al.
Neuroimage. Clinical|August 10, 2019
Neuronal injury biomarkers for assessment of the individual cognitive reserve in clinically suspected Alzheimer's diseaseLeonie Beyer, Jonas Schnabel, Philipp Kazmierczak, et al.
Frontiers in Aging Neuroscience|February 16, 2017
Increase of TREM2 during Aging of an Alzheimer's Disease Mouse Model Is Paralleled by Microglial Activation and AmyloidosisMatthias Brendel, Gernot Kleinberger, Federico Probst, et al.
Frontiers in Oncology|June 7, 2021
Feasibility of Different Tumor Delineation Approaches for <sup>18</sup>F-PSMA-1007 PET/CT Imaging in Prostate Cancer PatientsLena M Mittlmeier, Matthias Brendel, Leonie Beyer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 14, 2018
Outcome after PSMA PET/CT based salvage radiotherapy in patients with biochemical recurrence after radical prostatectomy: a bi-institutional retrospective analysisNina-Sophie Schmidt-Hegemann, Christian Stief, Tak-Hyun Kim, et al.
Pageof 55